NOVABAY PHARMACEUTICALS INC

Historical 13F Holders

Symbol
SDEV
CUSIP
66987P508
All holders as of
Q2 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 66987P508 since 12/18/2024, newest first.

Filer % of Class Filed
Sky Frontier Foundation 13D/A Amendment 3 9.9% 10/29/2026
Event 10/21/2026
Sky Frontier Foundation 13D/A Amendment 2 9.9% 8/21/2026
Event 8/17/2026
Tether Global Investments Fund, S.I.C.A.F., S.A. 13G/A Amendment 1
10.0% 8/17/2026
Event 6/30/2026
Framework Ventures IV L.P. 13D/A Amendment 6
46.6% 7/24/2026
Event 7/18/2026
R01 Fund LP 13D/A Amendment 7
52.4% 7/24/2026
Event 7/18/2026
Sky Frontier Foundation 13D/A Amendment 1 7.4% 7/22/2026
Event 6/15/2026
Framework Ventures IV L.P. 13D/A Amendment 5
45.9% 6/17/2026
Event 6/15/2026
R01 Fund LP 13D/A Amendment 6
49.8% 6/17/2026
Event 6/15/2026
Sky Frontier Foundation 13D 9.9% 5/27/2026
Event 5/17/2026
Tether Global Investments Fund, S.I.C.A.F., S.A. 13G
10.0% 5/22/2026
Event 5/17/2026
Framework Ventures IV L.P. 13D/A Amendment 4
46.4% 5/19/2026
Event 5/17/2026
R01 Fund LP 13D/A Amendment 5
50.3% 5/19/2026
Event 5/17/2026
R01 Fund LP 13D/A Amendment 4
52.8% 4/30/2026
Event 4/29/2026
Framework Ventures IV L.P. 13D/A Amendment 3
44.5% 4/30/2026
Event 4/29/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 9 542 k $1.40M
2026 Q2 22 1.48 M $1.55M
2026 Q1 25 1.64 M $2.44M